How HIV researchers overcame setbacks and kept a vaccine trial going
Scientists say research into a vaccine for HIV is further along than it’s ever been.
But Trump administration cuts to scientific research have set that effort back.
Including a promising trial for an HIV vaccine in Africa – which was shut down altogether.
NPR’s Ari Daniel has the story of how researchers there refused to give up.
Ari’s reporting for this story was supported by a grant from the Pulitzer Center. The Gates Foundation is a financial supporter of NPR.
This episode was produced by Mallory Yu and Kira Wakeam.
It was edited by Rebecca Davis and Courtney Dorning.
Our executive producer is Sami Yenigun.
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
NPR Privacy Policy
More description
Scientists say research into a vaccine for HIV is further along than it’s ever been.
But Trump administration cuts to scientific research have set that effort back.
Including a promising trial for an HIV vaccine in Africa – which was shut down altogether.
NPR’s Ari Daniel has the story of how researchers there refused to give up.
Ari’s reporting for this story was supported by a grant from the Pulitzer Center. The Gates Foundation is a financial supporter of NPR.
This episode was produced by Mallory Yu and Kira Wakeam.
It was edited by Rebecca Davis and Courtney Dorning.
Our executive producer is Sami Yenigun.
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
NPR Privacy Policy
Listen elsewhere
Available Results
Generated results are saved to your library for reuse and search.